%0 Journal Article
%T Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
%A Kristian Ikenberg
%A Florian R Fritzsche
%A Ursina Zuerrer-Haerdi
%A Irina Hofmann
%A Thomas Hermanns
%A Helge Seifert
%A Michael M¨¹ntener
%A Maurizio Provenzano
%A Tullio Sulser
%A Silvia Behnke
%A Josefine Gerhardt
%A Ashkan Mortezavi
%A Peter Wild
%A Ferdinand Hofst£¿dter
%A Maximilian Burger
%A Holger Moch
%A Glen Kristiansen
%J BMC Cancer
%D 2010
%I BioMed Central
%R 10.1186/1471-2407-10-341
%X Immunohistochemical stainings for IMP3 were performed on tissue microarray (TMA) organized samples from 507 patients: 31 normal prostate tissues, 425 primary carcinomas and 51 prostate cancer metastases or castration-resistant prostate cancers (CRPC). IMP3 immunoreactivity was semiquantitatively scored and correlated with clinical-pathologic parameters including survival.IMP3 is significantly stronger expressed in prostate carcinomas compared to normal prostate tissues (p < 0.0001), but did not show significant correlation with the pT-stage, the proliferation index (MIB1), preoperative serum PSA level and the margin status. Only a weak and slightly significant correlation was found with the Gleason score and IMP3 expression failed to show prognostic significance in clinico-pathological correlation-analyses.Although IMP3 is overexpressed in a significant proportion of prostate cancer cases, which might be of importance for novel therapeutic approaches, it does not appear to possess any immediate diagnostic or prognostic value, limiting its potential as a tissue biomarker for prostate cancer. These results might be corroborated by the fact, that two independent tumor cohorts were separately reviewed.Insulin-like growth factor II mRNA binding protein 3 (IMP3), an oncofetal protein and member of the insulin-like growth factor II mRNA binding protein family, has recently raised attention since it appears to play an important role in cell-migration and adhesion in various malignant neoplasms [1]. It functions in RNA shuttling and translational control: to date three members of this family are known: IMP1, IMP2 and IMP3 [2,3]. The human IMP3 gene is located at chromosome 7p15 with an identical sequence to that of KOC (KH domain containing protein overexpressed in cancer) and shows an overall sequence identitiy of 59% with other mRNA binding family members [4].Physiologically, IMP3 is commonly expressed during embryogenesis in mouse and human organs, but rarely in adult tis
%U http://www.biomedcentral.com/1471-2407/10/341